| dc.contributor.advisor | Azad, Md. Abul Kalam | |
| dc.contributor.author | Shimu, Sumaya | |
| dc.date.accessioned | 2022-12-08T04:47:44Z | |
| dc.date.available | 2022-12-08T04:47:44Z | |
| dc.date.copyright | 2022 | |
| dc.date.issued | 2022-01 | |
| dc.identifier.other | ID 17146038 | |
| dc.identifier.uri | http://hdl.handle.net/10361/17626 | |
| dc.description | This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022. | en_US |
| dc.description | Cataloged from PDF version of thesis. | |
| dc.description | Includes bibliographical references (pages 40-45). | |
| dc.description.abstract | Renal cancer is fourteenth most common cancer worldwide which is currently increasing in
alarming rate. Many people are dying of renal cancer every day. In this situation, finding out an
efficient treatment option has become a challenge to the scientists. Immunotherapy has brought a
significant impact in terms of treating the renal sarcoma patients by leveraging the immune system
and causing tumor regression. Due to having poor prognosis and respond in radiotherapy and
chemotherapy, this method of immunotherapy has expanded the opportunity of treatment. Renal
cell carcinoma (RCC) is considered to be the most immunogenic tumors in human body. Because
of being diffused by the cells of immune system, these cells perform very actively in the field of
immunotherapy. Immunotherapy has brought a great success and widened up several opportunities
for the patients. There has been developed several ways of immunotherapy treatment along with
analyzing the challenges and future aspects for this treatment. | en_US |
| dc.description.statementofresponsibility | Sumaya Shimu | |
| dc.format.extent | 45 pages | |
| dc.language.iso | en | en_US |
| dc.publisher | Brac University | en_US |
| dc.rights | Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. | |
| dc.subject | Immunotherapy | en_US |
| dc.subject | Renal Cell Carcinoma | en_US |
| dc.subject | Immune system | en_US |
| dc.subject | Success | en_US |
| dc.subject | Challenges | en_US |
| dc.subject | Possibilities | en_US |
| dc.subject.lcsh | Cancer Treatment | |
| dc.title | Immunotherapy in the treatment of renal cancer | en_US |
| dc.type | Thesis | en_US |
| dc.contributor.department | Department of Pharmacy, Brac University | |
| dc.description.degree | B. Pharmacy | |
